Royal Bank Of Canada Foghorn Therapeutics Inc. Transaction History
Royal Bank Of Canada
- $458 Billion
- Q1 2025
A detailed history of Royal Bank Of Canada transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 34 shares of FHTX stock, worth $141. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34
Previous 2,589
98.69%
Holding current value
$141
Previous $12,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding FHTX
# of Institutions
89Shares Held
36.7MCall Options Held
100Put Options Held
0-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$52.9 Million19.62% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$22.1 Million0.85% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.26MShares$13.6 Million0.3% of portfolio
-
Raymond James & Associates St Petersburg, FL2.3MShares$9.58 Million0.01% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL2.22MShares$9.25 Million0.0% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $174M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...